Taysha Gene Therapies, Inc.

TSHA · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $1.8B · 99 employees
130
SEC Filings
$5.97
Close 2026-06-01
99
Employees

Business Summary

, Part I, Item 1A. Risk Factors, and Part II, Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations, but are also contained elsewhere in this Annual Report. In some cases, you can identify forward-looking statements by the words may, might, will, could, would, should, expect, intend, plan, objective, anticipate, believe, estimate, predict, project, potential, continue and ongoing, or the negative of these terms, or other comparable terminology intended to i...

Latest Stock Quote

TSHA 2026-06-01 $5.97 O:$5.81 H:$5.99 L:$5.55 Vol:1.6M VWAP:$5.8851
origin leaf: 82b83cd5c5605afd0e7c03d1bd8a5f2b895295e3b329b2eb0b9a5a2ec19fa311

Next Earnings

Q2 FY2026 — expected 2026-08-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001193125-26-115202EDGAR109K words
2025-02-262024-12-310000950170-25-027348EDGAR
2024-03-192023-12-310000950170-24-033484EDGAR
2023-03-282022-12-310000950170-23-010343EDGAR
2022-03-312021-12-310001564590-22-012782EDGAR
2021-03-032020-12-310001564590-21-010433EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-263506EDGAR41K words
2025-08-122025-06-300000950170-25-107010EDGAR
2025-05-152025-03-310000950170-25-072036EDGAR
2024-11-132024-09-300000950170-24-126416EDGAR
2024-08-122024-06-300000950170-24-095082EDGAR
2024-05-142024-03-310000950170-24-059555EDGAR
2023-11-142023-09-300000950170-23-063734EDGAR
2023-08-142023-06-300000950170-23-042089EDGAR
2023-05-112023-03-310000950170-23-021333EDGAR
2022-11-082022-09-300001564590-22-036936EDGAR
2022-08-112022-06-300001564590-22-029155EDGAR
2022-05-162022-03-310001564590-22-020260EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001193125-26-115177EDGAR3K words
2025-11-040001193125-25-263543EDGAR
2025-10-160001193125-25-241415EDGAR
2025-10-090001193125-25-235212EDGAR
2025-10-020001193125-25-227505EDGAR
2025-08-120001193125-25-178504EDGAR
2025-06-030001193125-25-133745EDGAR
2025-05-290001193125-25-130709EDGAR
2025-05-280001193125-25-129494EDGAR
2025-05-150001193125-25-120329EDGAR

130 total filings indexed. 102 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001806310
TickerTSHA
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.tayshagtx.com
Listed2020-09-24

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 077b7542bc5080c21969b07561c131e174e546a7f7d494ba5aa26200498f6c47
parent: 44a04880fdebc90984361ce68d39ab9d4efe5131e3a9a3c30c608ecd12a011be
content hash: ae73410e90eede00387566e48b9e6f1c2fc7e8f85a71786d5234b4e42c7b68e8
signed: 2026-06-02T19:02:54.560Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf